| Red Metal Limited (RDM) ORDINARY FULLY PAID |
Materials |
$49 |
Sybella Optimisation Tests Validate Heap Leach Potential
|
19 May 2025 11:02AM |
$0.105 |
$0.128 |
risen by
21.43%
|
|
RDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Metal Limited completed Sybella heap leach optimisation tests.
- Testwork included column leach and bottle roll testing on Sybella oxide and transition ores.
- Rapid copper extraction and high recoveries were achieved under acid leach conditions.
- Results validate the heap leach potential of the Sybella copper project.
- Testing supports the feasibility of a heap leach-SX-EW operation for copper production.
- The company plans further metallurgical, mine planning, and development studies.
- Positive results provide a foundation for progressing the Sybella project towards development.
- The project demonstrates potential for low-cost, scalable copper production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chilwa Minerals Ltd (CHW) ORDINARY FULLY PAID |
Materials |
$83 |
Change of Director's Interest Notice
|
19 May 2025 11:00AM |
$0.735 |
$0.865 |
risen by
17.69%
|
|
| Critical Minerals Group Limited (CMG) ORDINARY FULLY PAID |
Materials |
$10 |
Results of Entitlement Offer
|
19 May 2025 10:52AM |
$0.110 |
$0.097 |
fallen by
11.82%
|
|
| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$17 |
Upper Austrian Shallow Gas Play Update
|
19 May 2025 10:49AM |
$0.028 |
$0.023 |
fallen by
17.86%
|
|
ADX - Price-sensitive ASX Announcement
Full Release
Key Points
- ADX Energy Ltd has provided an update on its Upper Austrian shallow gas exploration activities.
- The company has reported on the drilling and testing of the Anshof-2 and Anshof-3 gas wells.
- Initial testing of the Anshof-2 well confirmed the presence of commercial gas flows from the primary target zones.
- Anshof-3 well results have indicated the discovery of additional gas-bearing zones.
- The company is progressing with plans to connect the Anshof wells to existing infrastructure for early gas sales.
- ADX Energy Ltd has outlined its strategy to exploit the shallow gas potential in Upper Austria using modern exploration and production techniques.
- The update highlights the proximity of the discovered resources to infrastructure, providing a pathway for rapid monetization.
- Ongoing technical studies and further appraisal work are planned to optimize field development and maximize gas recovery.
- ADX Energy is also assessing additional exploration opportunities in the broader Upper Austrian license area.
- The company emphasizes the significance of these results for its growth strategy and regional energy supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$224 |
Cleansing Notice
|
19 May 2025 10:49AM |
$0.007 |
$0.105 |
risen by
1,400%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$224 |
Application for quotation of securities - W2V
|
19 May 2025 10:46AM |
$0.007 |
$0.105 |
risen by
1,400%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$224 |
Application for quotation of securities - W2V
|
19 May 2025 10:44AM |
$0.007 |
$0.105 |
risen by
1,400%
|
|
| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$176 |
Notice of General Meeting/Proxy Form
|
19 May 2025 10:44AM |
$0.145 |
$0.358 |
risen by
146.55%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$224 |
Notification regarding unquoted securities - W2V
|
19 May 2025 10:43AM |
$0.007 |
$0.105 |
risen by
1,400%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$20 |
AGM - Chairman & CEO Addresses and Presentation
|
19 May 2025 10:37AM |
$0.330 |
$0.370 |
risen by
12.12%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Chairman and CEO deliver addresses at the ImExHS Limited AGM.
- Overview of operational performance and strategic direction.
- Highlights of recent achievements and progress in product innovation.
- Challenges faced by the company and responses implemented.
- Emphasis on financial performance, cost management, and shareholder value.
- Continued focus on medical imaging technology and healthcare solutions.
- Plans for future growth, expansion, and market opportunities.
- Acknowledgments to staff, partners, and shareholders for their support.
- Commitment to ongoing operational efficiency improvements.
- Strategic initiatives to drive sustainable growth and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$58 |
Notice under Section 708A(5)(e) of the Corporations Act
|
19 May 2025 10:36AM |
$0.800 |
$0.730 |
fallen by
8.75%
|
|
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$738 |
Notification regarding unquoted securities - SHV
|
19 May 2025 10:32AM |
$4.880 |
$5.190 |
risen by
6.35%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$58 |
Application for quotation of securities - UBN
|
19 May 2025 10:32AM |
$0.800 |
$0.730 |
fallen by
8.75%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$8 |
$900K Capital Raise to Accelerate Smart Inhaler in US
|
19 May 2025 10:31AM |
$0.007 |
$0.003 |
fallen by
57.14%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Adherium Limited announced a $900,000 capital raise.
- Funds will accelerate the Hailie® Smartinhalerâ„¢ commercialisation in the US.
- The raise is via a placement to sophisticated and professional investors.
- Primary use of funds: US market expansion, product development, regulatory activities.
- Focus on digital respiratory health, medication adherence, and disease management.
- Strong clinical evidence supports the Smartinhalerâ„¢ technology.
- Adherium is engaging with payers and partners in the US.
- Placement strengthens Adherium’s position in the US digital health market.
- Strategic emphasis on asthma and COPD management.
- Details provided on allocation of capital and next steps for US operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$20 |
Notification of cessation of securities - BNL
|
19 May 2025 10:29AM |
$0.007 |
$0.006 |
fallen by
21.43%
|
|
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
Change in substantial holding
|
19 May 2025 10:29AM |
$0.026 |
$0.021 |
fallen by
19.23%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$34 |
Customer Update & US Market Strategy
|
19 May 2025 10:29AM |
$0.019 |
$0.033 |
risen by
73.68%
|
|
HMD - Price-sensitive ASX Announcement
Full Release
Key Points
- HeraMED Limited (HeraMED or the Company) provides an update regarding its customer pipeline and strategic focus on the US market.
- The Company has experienced delays in revenue realisation from existing contracts, particularly with Sheba Medical Center and Joondalup Health Campus, due to slower-than-expected implementations.
- A new partnership agreement has been signed with HMC Group to expand the commercialisation of HeraCARE in the US market.
- HeraMED is focusing on commercialising its remote monitoring and maternity care solutions in the US, where there is high demand for maternal health support and digital health innovation.
- The Company’s US go-to-market strategy includes targeting private healthcare providers, insurers, and strategic partners to accelerate adoption.
- The update acknowledges that while existing contracts are progressing, revenue uptake has lagged behind initial expectations, hence the increased focus on US opportunities.
- HeraMED has a robust sales pipeline and continues to pursue further contracts and pilot programs with healthcare organisations globally.
- The Company is implementing measures to manage cash flow and reduce costs in the interim period to ensure ongoing operations.
- The Board remains confident in the long-term commercial potential of HeraMED’s technology and its ability to benefit from structural shifts in healthcare delivery, especially in the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$58 |
Update - Application for quotation of securities - UBN
|
19 May 2025 10:27AM |
$0.800 |
$0.730 |
fallen by
8.75%
|
|
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$294 |
GVF Investor Presentation May 2025
|
19 May 2025 10:25AM |
$1.345 |
$1.455 |
risen by
8.18%
|
|
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$205 |
Notification regarding unquoted securities - EGH
|
19 May 2025 10:21AM |
$0.530 |
$0.480 |
fallen by
9.43%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$96 |
Ceasing to be a substantial holder
|
19 May 2025 10:21AM |
$0.715 |
$0.880 |
risen by
23.08%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$38 |
Investor Presentation
|
19 May 2025 10:19AM |
$0.750 |
$0.295 |
fallen by
60.67%
|
|
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$18 |
Notice of Annual General Meeting/Proxy Form
|
19 May 2025 10:16AM |
$0.032 |
$0.022 |
fallen by
31.25%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$8 |
Cleansing Notice - Options
|
19 May 2025 10:14AM |
$0.070 |
$0.080 |
risen by
14.29%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$8 |
Application for quotation of securities - AXL
|
19 May 2025 10:10AM |
$0.070 |
$0.080 |
risen by
14.29%
|
|